Reply to A. Shinde et al

Harriet M. Kluger; Kim A. Margolin; Michael A. Davies; Georgina V. Long; Hussein A. Tawbi; Sarah B. Goldberg; Veronica L. Chiang

doi:10.1200/JCO.18.02463

Reply to A. Shinde et al

Harriet M. Kluger, Kim A. Margolin, Michael A. Davies, Georgina V. Long, Hussein A. Tawbi, Sarah B. Goldberg, Veronica L. Chiang

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1031-1032
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	37
Issue number	12
DOIs	https://doi.org/10.1200/JCO.18.02463
State	Published - 2019

Access to Document

10.1200/JCO.18.02463

Cite this

@article{a48d812698664716a0036a86d3b40360,

title = "Reply to A. Shinde et al",

author = "Kluger, {Harriet M.} and Margolin, {Kim A.} and Davies, {Michael A.} and Long, {Georgina V.} and Tawbi, {Hussein A.} and Goldberg, {Sarah B.} and Chiang, {Veronica L.}",

note = "Funding Information: ACKNOWLEDGMENT The clinical trial was supported by the Yale Cancer Center and Merck.",

year = "2019",

doi = "10.1200/JCO.18.02463",

language = "English",

volume = "37",

pages = "1031--1032",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Reply to A. Shinde et al

AU - Kluger, Harriet M.

AU - Margolin, Kim A.

AU - Davies, Michael A.

AU - Long, Georgina V.

AU - Tawbi, Hussein A.

AU - Goldberg, Sarah B.

AU - Chiang, Veronica L.

N1 - Funding Information: ACKNOWLEDGMENT The clinical trial was supported by the Yale Cancer Center and Merck.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85065040638&partnerID=8YFLogxK

U2 - 10.1200/JCO.18.02463

DO - 10.1200/JCO.18.02463

M3 - Letter

C2 - 30807233

AN - SCOPUS:85065040638

SN - 0732-183X

VL - 37

SP - 1031

EP - 1032

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 12

ER -

Reply to A. Shinde et al

Access to Document

Other files and links

Cite this